To briefly summarize the epidemiologic findings of selected lifestyle factors for prostate cancer progression, metastasis, or death, with a focus on behaviors after diagnosis where possible. We conclude by providing guidance on the lifestyle practices that physicians may wish to prioritize for discussion with their patients.
INTRODUCTION
More than 2.6 million men in the USA are prostate cancer survivors who may potentially improve their prognosis by adopting healthier lifestyle habits [1] . Our research group and others have evaluated whether lifestyle factors after diagnosis are associated with risks of recurrence or prostate-cancerspecific mortality.
Given the heterogeneity of prostate cancer and the advent of prostate-specific antigen (PSA) screening, it is increasingly important that epidemiologic research focus on the outcomes of aggressive prostate cancer, prostate cancer progression, or prostate cancer death, rather than simply overall prostate cancer incidence. Risk factors for total incident prostate cancer may differ from those for aggressive and fatal disease [2] , and combining all incident prostate cancer cases can lead to incorrect conclusions. In this report, we briefly summarize the epidemiologic findings of selected lifestyle factors for prostate cancer progression, metastasis, or death, with a focus on behaviors after diagnosis where possible. We conclude by providing guidance on lifestyle practices that physicians may wish to prioritize for discussion with their patients.
SMOKING AND PROSTATE CANCER
Data are highly suggestive that there is a greater risk of death from prostate cancer in smokers than in nonsmokers and that, among men who have prostate cancer, there is a greater risk of aggressive prostate cancer (e.g. worse stage or grade) in smokers than in nonsmokers [3] . Furthermore, smokers have a higher risk of prostate cancer progression, independent of the stage and grade [3] .
Several studies reported that smoking is associated with progression of the disease after diagnosis, including the development of biochemical recurrence, metastasis, and hormone-refractory prostate cancer. With 22 years of follow-up and many outcomes in the Health Professionals Follow-up Study (HPFS; 524 prostate-cancer-specific deaths and 878 biochemical recurrences), we reported that current smoking was associated with an approximately 60% increased risk of prostate cancer mortality and biochemical recurrence (hazard ratio 1.61, 95% confidence interval [CI] 1.11-2.32 and hazard ratio 1.61, 95% CI 1.16-1.22, respectively) [4] . Compared to current smokers, those who had quit smoking for at least 10 years, or who had quit for less than 10 years but smoked less than 20 pack-years, had prostatecancer-specific mortality risks similar to never smokers, whereas those who had quit for less than 10 years and had smoked at least 20 pack-years had risks similar to current smokers. Two smaller studies also reported a positive association between smoking and prostate-cancer-specific mortality, based on few prostate cancer deaths [5, 6] . In summary, men with prostate cancer should be counseled to quit smoking and provided with referrals to obtain smoking cessation support.
PHYSICAL ACTIVITY AND PROSTATE CANCER
Aerobic exercise may reduce prostate cancer progression and prostate-cancer-specific death by influencing energy metabolism, inflammation, oxidative stress, and androgen receptor signaling pathways. Accumulating evidence from prospective cohort studies suggests that physical activity, specifically vigorous activity (i.e. activities that require an energy expenditure 6 times the resting metabolic rate, such as jogging or bicycling), is associated with reduced risk of advanced, aggressive, and fatal prostate cancer. Our group was the first to report on physical activity after diagnosis in relation to prostate-cancer-specific and total mortality in the HPFS [7] . We observed that at least 3 h per week of vigorous activity after diagnosis vs. less than 1 h per week was significantly inversely associated with not only total mortality (which was anticipated), but also with an approximately 60% reduction in risk of prostate-cancer-specific mortality (P trend ¼ 0.03; Fig. 1a ), independent of clinical, demographic, and other lifestyle factors. We observed similar results among 1455 men in the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) examining the risk of prostate cancer progression, although the results were not statistically significant ( Fig. 1a ). In CaPSURE, progression was primarily measured by biochemical recurrence or undergoing secondary treatment; these results were very
KEY POINTS
Engaging in vigorous physical activity or brisk walking after diagnosis of prostate cancer may reduce the risk of disease progression, prostate-cancer-specific mortality, and all-cause mortality.
Substituting vegetable fats for animal fats and carbohydrates after prostate cancer diagnosis may reduce the risk of all-cause mortality.
There is no strong evidence that any supplement is beneficial for men with prostate cancer; caution is warranted for several supplements (e.g. selenium, vitamin E, and beta-carotene). compelling as there was less potential for reverse causation as physical symptoms of prostate cancer progression that may cause a decrease in physical activity are unlikely to precede biochemical recurrence.
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We also observed a benefit of brisk walking in both cohorts ( Fig. 1b) , with the association reaching statistical significance for the outcome of progression in CaPSURE. Although compelling and complementary, these studies warrant confirmation in distinct cohorts; and it remains to be elucidated what biological mechanisms underlie these findings. Together, these data suggest that an aspect of engaging in relatively vigorous physical activity and having higher cardiorespiratory fitness may protect against prostate cancer progression.
BODY SIZE AND PROSTATE CANCER
Increasing evidence suggests that obesity (either before or at the time of diagnosis) is strongly associated with prostate cancer progression and prostatecancer-specific mortality, independent of lifestyle or clinical factors. For example, among 2546 men diagnosed with localized prostate cancer in the Physicians' Health Study, a one-unit increase in prediagnostic BMI was associated with approximately 10% increase in the risk of prostate-cancerspecific mortality, and BMI of at least 30 kg/m 2 was associated with a nearly two-fold increased risk of prostate cancer death (relative risk [RR] 1.95, 95% CI 1.17-3.23) [8] . A meta-analysis of six studies in prostate cancer patients reported that a 5 kg/m 2 increase in BMI increased the risk of prostatecancer-specific mortality by 20% and biochemical recurrence by 21% [9] .
DIET AND PROSTATE CANCER
Whereas some foods and nutrients assessed prior to diagnosis have been associated with advanced, metastatic, or fatal prostate cancer [10] , few studies have examined postdiagnostic intake of foods and nutrients in relation to risk of prostate cancer recurrence and prostate-cancer-specific mortality.
Fruit and vegetables
In the first study to examine the relation of postdiagnosis diet with risk of progression using data from the HPFS, we reported a 20% lower risk of progression (mostly biochemical progression) for two servings per week increase of tomato sauce (P trend ¼ 0.04) [11] . In contrast, there was no association between postdiagnostic tomato sauce intake and risk of prostate cancer progression in CaPSURE [11] . Studies are underway to clarify these findings for the more clinically relevant outcome of prostate cancer death.
A benefit with increased intake of cruciferous vegetables was reported in CaPSURE, in which men in the highest vs. lowest quartile of postdiagnostic intake of cruciferous vegetables had a statistically significant 59% decreased risk of prostate cancer progression (P trend ¼ 0.003) [12 & ]. There is evidence from in-vitro and in-vivo studies suggesting anticarcinogenic effects of metabolites of cruciferous vegetables, including glucosinolates, isothiocyanates, and indoles, which supports the biologic plausibility of a benefit of consuming cruciferous vegetables for men with prostate cancer [13] [14] [15] [16] . However, additional research is needed from randomized controlled trials in humans to determine whether this association is causal.
Legumes
Meta-analyses of observational studies examining soy intake and incident prostate cancer have generally suggested an inverse association, although the data are predominantly driven by the studies conducted in Asian populations, in which the intake of soy products is substantially higher than US or European populations [17, 18] . A recent randomized masked clinical trial examining a soy protein supplement vs. placebo reported null results for the outcome of biochemical recurrence; this study was conducted among primarily Caucasian men at high risk for recurrence after surgery [19 & ].
Fish
In the first study to examine the relation of postdiagnosis diet with risk of progression using data from the HPFS, we observed a 17% lower risk (P trend ¼ 0.006) of progression for two servings per week increase of fish intake [11] . However, there was no association between fish intake after diagnosis and risk of prostate cancer progression in CaPSURE [20] . Studies are underway to clarify these findings for the more clinically relevant outcome of prostate cancer death. Additionally, a few large prospective studies with long follow-up have reported on an inverse association (i.e., benefit) between fish consumption (before diagnosis of prostate cancer) and the subsequent risk of prostate cancer death [21, 22] . Furthermore, among men scheduled for surgery for prostate cancer, an intervention comprising 4-6 weeks of a low-fat and fish-oil-supplemented diet was associated with lower prostate tumor proliferation biomarkers (i.e., cell cycle progression score and ki67, assessed in their radical prostatectomy specimens) compared with assignment to a Western diet [23,24].
Red and processed meat
There is limited evidence to suggest that greater intake of meat (red and processed meat) after diagnosis may increase the risk of prostate cancer progression or death. In HPFS and CaPSURE, processed red meat was positively associated with risk of prostate cancer death and recurrence, respectively, but neither association was statistically significant. Unprocessed red meat intake after diagnosis was not associated with risk of prostate cancer death or recurrence in the HPFS or CaPSURE, respectively [25] . Nevertheless, given that cardiovascular disease is the number one cause of death among men diagnosed with localized prostate cancer, it is prudent to advise men to limit the intake of processed red meat after diagnosis. This is also supported by Strom et al.
[26], who reported a two-fold increased risk of biochemical recurrence with greater saturated fat consumption among 390 men who underwent radical prostatectomy for organ-confined prostate cancer at diagnosis. Recently, we reported that replacing 10% of energy intake from animal fat with vegetable fat after diagnosis of nonmetastatic prostate cancer was associated with a significant 34% lower risk of death from all causes (P-value <0.001). Moreover, replacing 10% of calories from carbohydrate with vegetable fat was associated with a 29% lower risk of lethal prostate cancer
Coffee
Although data are limited and not entirely consistent, observational studies suggest a benefit for greater consumption of coffee and risks of all-cause mortality, as well as advanced or lethal prostate cancer and prostate cancer recurrence (note: coffee intake was assessed before diagnosis and studies have yet to specifically address the question of coffee intake after diagnosis) 
MULTIVITAMINS, SUPPLEMENTS, AND PROSTATE CANCER
At this time, there is no strong evidence that any single supplement or multivitamin may offer protection against prostate cancer (incidence, progression, or death); and in fact caution is warranted in the usage of several supplements (e.g. selenium, vitamin E, and beta-carotene) [39-43,44 & ]. For example, among approximately 4400 men initially diagnosed with localized prostate cancer, we observed more than 2.5-fold increased risk of prostate cancer death among men who reported taking at least 140 mg/day of supplemental selenium compared with those taking none (RR 2.60, 95% CI1.44-4.70) [45] .
COMBINED HEALTHY LIFESTYLE PRACTICES
Though the data are limited and mainly focused on assessments of behaviors before diagnosis, research suggests that practicing multiple healthy lifestyle habits in combination may offer protection against developing lethal prostate cancer. Our group has reported that engaging in 5-6 healthy behaviors before diagnosis (i.e., not smoking or quitting smoking 10 years ago, having a BMI less than 30 kg/m 2 , engaging in vigorous physical activity or brisk walking, and consuming greater amounts of tomatoes and dark (fatty) fish and less processed meat) was associated with nearly a 40% decreased risk of lethal prostate cancer compared with men who reported only one or none of these behaviors (hazard ratio 0.61, 95% CI 0.42-0.88; P trend ¼ 0.0009) in the HPFS. This finding was confirmed in a distinct population of men (Physicians Health Study) [46] . Additionally, data from a small pilot trial of 30 men with early-stage, low-grade prostate cancer on active surveillance who adopted comprehensive lifestyle changes (low-fat, wholefood, plant-based diet supplemented with soy, fish oil, vitamin E and selenium, moderate exercise, support group, and meditation/stress reduction) indicated alterations in the tumor microenvironment and circulating telomerase levels that were suggestive of cancer protection (benefit) after 3 months [47, 48] . Although provocative, this trial was small and did not have a randomized control group. Future randomized controlled trials in larger populations of men with prostate cancer are warranted to confirm these findings and directly address whether behavior change after diagnosis can improve survival outcomes.
CONCLUSION
Growing, but still limited, evidence suggests that lifestyle factors after prostate cancer diagnosis may impact prostate-cancer-specific and overall mortality. In particular, smoking and obesity may increase the risk of disease progression and mortality, whereas engaging in vigorous physical activity or brisk walking and consuming a diet rich in vegetables (particularly tomato sauce and cruciferous) and vegetable fats may lower the risk. On the basis of these findings and extensive data from cardiovascular disease research, we suggest the following recommendations for men with prostate cancer. ], provides data from randomized clinical trials of nutritional supplements and multivitamins, and reports null results for prostatecancer-specific outcomes. These in part underly the recommendation that no specific supplement should be recommended at this time for prostate cancer secondary prevention. ], provides novel data regarding the emerging hypothesis that coffee consumption may offer benefits for overall mortality, as well as protect against prostate-cancer-specific progression and mortality.
